Parthenon Capital has made a strategic growth investment in Medical Review Institute of America (MRIoA), a leading provider of outsourced utilization management and clinical review solutions. This investment signals Parthenon’s confidence in MRIoA’s automation-enabled solutions and positions the company for continued growth. Alongside this, MRIoA’s management and existing investor Summit Partners will retain significant stakes in the business. The deal underscores MRIoA’s commitment to enhancing clinical care delivery through its extensive review network and technological advancements. Dan Killeen and Dave Ament of Parthenon expressed their excitement in partnering with MRIoA, given its crucial role in facilitating timely patient care. Mizuho and Greenhill & Co. served as MRIoA’s financial advisors, while Parthenon’s legal advisement was provided by Kirkland & Ellis, LLP.

Healthcare Services, Private Equity, Technology Services,United States

Parthenon Capital Announces Strategic Growth Investment in Medical Review Institute of America